Campbell & CO Investment Adviser LLC Uni Qure N.V. Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$20.24 - $36.01 $437,183 - $777,816	-21,600 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$26.01 - $38.22 $561,816 - $825,552	21,600 New	21,600 $691,000
Q1 2020 Apr 29, 2020	SELL	$40.01 - $73.97 $166,121 - $307,123	-4,152 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$37.13 - $74.62 $154,163 - $309,822	4,152 New	4,152 $298,000
Q3 2019 Oct 16, 2019	SELL	$39.36 - $76.8 $124,377 - $242,688	-3,160 Closed	0 $0
Q2 2019 Jul 10, 2019	SELL	$52.76 - $82.19 $33,766 - $52,601	-640 Reduced 16.84%	3,160 $247,000
Q1 2019 May 10, 2019	BUY	$27.39 - $68.41 $104,082 - $259,958	3,800 New	3,800 $227,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.